Praxis Precision Medicines, Inc. (PRAX)
Nasdaq: PRAX · Pharmaceutical Preparations · Boston, MA · filing with the SEC since 2016
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
| Report filed | Feb 19, 2026 | Feb 28, 2025 | Mar 5, 2024 | Feb 7, 2023 | Feb 28, 2022 | Mar 17, 2021 | · |
| Revenue | 0 | 8,553 | 2,447 | 0 | · | · | · |
| Research and development | 267,115 | 152,413 | 86,766 | 155,040 | 120,257 | 44,976 | 29,557 |
| General and administrative | 59,083 | 56,305 | 42,054 | 59,946 | 47,075 | 16,992 | 6,232 |
| Total operating expenses | 326,198 | 208,718 | 128,820 | 214,986 | 167,332 | 61,968 | 35,789 |
| Operating income | -326,198 | -200,165 | -126,373 | -214,986 | -167,332 | -61,968 | -35,789 |
| Interest and investment income | · | · | · | 957 | 271 | 140 | 193 |
| Other income (expense), net | 22,930 | 17,346 | 3,096 | 957 | · | · | · |
| Total non-operating income (expense) | 22,930 | 17,346 | 3,096 | 957 | 271 | 140 | 193 |
| Income before income taxes | -302,797 | -182,743 | -123,013 | · | -167,061 | -61,828 | -35,596 |
| Income tax expense | 471 | · | · | · | 0 | -8 | -84 |
| Net income | -303,268 | -182,819 | -123,277 | -214,029 | -167,061 | -61,820 | -35,512 |
| Net income to common shareholders | · | · | · | · | -167,061 | -70,323 | -40,682 |
| Earnings per share, basic | -13.48 | -10.21 | -18.69 | -69.65r | -59.10b | -117.90b | · |
| Earnings per share, diluted | -13.48 | -10.21 | -18.69 | -69.65r | -59.10b | -117.90b | · |
| Earnings per share, basic and diluted | · | · | · | · | · | -117.90b | -399.00b |
| Weighted average shares, basic | 22,504,676 | 17,906,794 | 6,594,316 | 3,073,100r | 2,830,270b | 596,677b | · |
| Weighted average shares, diluted | 22,504,676 | 17,906,794 | 6,594,316 | 3,073,100r | 2,830,270b | 596,677b | · |
| Weighted average shares, basic and diluted | · | · | · | · | · | 596,677b | 101,975b |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-15 reverse split of Nov 2023.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest and investment income what its cash and investments earned
us-gaap:InterestIncomeOtherOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted